Afsana Sabrin, PhD

Afsana Sabrin, PhD, has a diverse work experience in various scientific research and industry roles. Afsana is currently a Senior Scientist at EvolveImmune Therapeutics, starting in 2023. Prior to this, they worked at AMR Insights from 2020 to 2023 as an Ambassador.

From 2021 to 2023, Afsana Sabrin worked as a Research Scientist at Columbia University Irving Medical Center, focusing on clinical biomarker and drug discovery in neurodegeneration. Afsana'sresponsibilities included leading projects such as generating cellular disease models for Alzheimer's disease, conducting gene editing experiments, and analyzing transcriptomic and proteomic data. Afsana also conducted in vitro drug screening and identified glucocorticoid receptor agonists as potential therapeutic compounds for multiple sclerosis.

From 2019 to 2021, they worked at Albert Einstein College of Medicine, where they held multiple roles. As a Senator at Einstein Senate, they actively participated in the institution's governance. Afsana also worked as a Research Fellow, specifically in the field of oncology and macromolecular therapeutics development. Afsana'swork involved molecular cloning, drug screening, and determining small molecule inhibitors for prostate cancer.

Prior to their time at Albert Einstein College of Medicine, Afsana Sabrin gained valuable experience as a Graduate Assistant at Louisiana State University from 2013 to 2019. During their PhD program, they led various projects and collaborated with other research groups. Afsana'swork focused on molecular biology, immunology, and protein biochemistry. Afsana also gained experience in bacterial and eukaryotic expression systems, cell culture, and investigating gene regulations and protein functions.

Afsana Sabrin's earliest industry experience was as a Research Scientist in immunology, biochemistry, and molecular biology at ICDDR,B from 2008 to 2011. Afsana worked on a project involving the validation of an ALS assay for detecting tuberculosis in HIV and non-HIV patients.

Overall, Afsana Sabrin, PhD, has a strong background in scientific research, with expertise in various fields such as neurodegeneration, oncology, and immunology. Afsana has demonstrated their abilities in leading projects, conducting experiments, and collaborating with other research groups.

Afsana Sabrin, PhD, has a strong educational background in Biological Sciences. Afsana completed their Bachelor of Science (BS) degree in Biochemistry and Molecular Biology at the University of Dhaka from 2004 to 2008. Following this, they pursued a Master of Science (MS) degree in Biochemistry and Molecular Biology at the University of Dhaka from 2009 to 2010.

Afsana went on to achieve a significant milestone in their academic journey by obtaining a Doctor of Philosophy (Ph.D.) degree in Biological Sciences from Louisiana State University between 2014 and 2019. Afsana'sdoctoral research likely focused on aspects of Biological Sciences, although the specific field of study is not provided.

In terms of additional certifications, Afsana Sabrin obtained the Collaborative Institutional Training Initiative (CITI Program) certification in July 2016. Unfortunately, there is no information available regarding the institution from which they obtained this certification.

There are a few other educational institutions mentioned, such as Columbia University and Columbia University Irving Medical Center, but no specific degree or field of study information is provided for these institutions. Likewise, the Albert Einstein College of Medicine is mentioned, but no details regarding any degree or field of study are available.

Overall, Afsana Sabrin, PhD, has demonstrated a strong academic background in Biological Sciences through their extensive education and research experiences.